An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Clinical trial NCT06008938 · RECRUITING
Trial details
- NCT number
- NCT06008938
- Sponsor
- CSL Behring
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-15
- Primary completion
- 2043-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.